This mechanism links a master regulator of cell division directly to serine metabolism reprogramming, suggesting that therapeutic targeting of the SSP, serine uptake, or downstream lipid synthesis may be particularly relevant in PLK1-high advanced cancers. This evidence concerns the gene PLK1 and cancer.